EADB: An estrogenic activity database for assessing potential endocrine activity

Toxicological Sciences

Volumn 135, Issue 2, 2013, Pages 277-291

  Shen, J ^a   Xu, Lei ^b   Fang, Hong ^a   Richard, Ann M ^c   Bray, Jeffrey D ^d   Judson, Richard S ^c   Zhou, Guangxu ^a   Colatsky, Thomas J ^d   Aungst, Jason L ^d   Teng, Christina ^e   Harris, Steve C ^a   Ge, Weigong ^a   Dai, Susie Y ^f   Su, Zhenqiang ^a   Jacobs, Abigail C ^d   Harrouk, Wafa ^d   Perkins, Roger ^a   Tong, Weida ^a   Hong, Huixiao ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^b CHANG'AN UNIVERSITY   (China)

^c U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^d CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^e NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^f TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Database; Endocrine disruptor; Estrogen receptor; Estrogenic activity

Indexed keywords

ENDOCRINE DISRUPTOR; ESTROGEN RECEPTOR;

ARTICLE; CELL PROLIFERATION; DATA BASE; ESTROGEN ACTIVITY; HUMAN; IN VIVO STUDY; NONHUMAN; RECEPTOR BINDING; REPORTER GENE; RISK BENEFIT ANALYSIS; SAFETY; SIGNAL TRANSDUCTION;

DATABASE.; ENDOCRINE DISRUPTOR; ESTROGEN RECEPTOR; ESTROGENIC ACTIVITY;

ANIMALS; DATABASES, CHEMICAL; ENDOCRINE DISRUPTORS; ENDOCRINE GLANDS; ESTROGENS; HUMANS;

EID: 84886542100     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kft164     Document Type: Article

References (39)

1. Blair, R. M., Fang, H., Branham, W. S., Hass, B. S., Dial, S. L., Moland, C. L., Tong, W., Shi, L., Perkins, R., and Sheehan, D. M. (2000). The estrogen receptor relative binding affinities of 188 natural and xenochemicals: Structural diversity of ligands. Toxicol. Sci. 54, 138-153.
2. Branham, W. S., Dial, S. L., Moland, C. L., Hass, B. S., Blair, R. M., Fang, H., Shi, L., Tong, W., Perkins, R. G., and Sheehan, D. M. (2002). Phytoestrogens and mycoestrogens bind to the rat uterine estrogen receptor. J. Nutr. 132, 658-664.
3. Daston, G. P., Cook, J. C., and Kavlock, R. J. (2003). Uncertainties for endocrine disrupters: Our view on progress. Toxicol. Sci. 74, 245-252.
4. Davis, A. P., Murphy, C. G., Johnson, R., Lay, J. M., Lennon-Hopkins, K., Saraceni-Richards, C., Sciaky, D., King, B. L., Rosenstein, M. C., Wiegers, T. C., et al. (2013). The Comparative Toxicogenomics Database: Update 2013. Nucleic Acids Res. 41, D1104-D1114.
5. De Coster, S., and van Larebeke, N. (2012). Endocrine-disrupting chemicals: Associated disorders and mechanisms of action. J. Environ. Public Health 2012, 713696.
6. Ding, D., Xu, L., Fang, H., Hong, H., Perkins, R., Harris, S., Bearden, E. D., Shi, L., and Tong, W. (2010). The EDKB: An established knowledge base for endocrine disrupting chemicals. BMC Bioinformatics 11(Suppl. 6), S5.
7. EPA. (1998). Endocrine Disruptor Screening Program. Available at: http://www.epa.gov/endo/pubs/081198frnotice.pdf. Accessed November 15, 2012.
8. EPA. (2011). EDSP21 Work Plan. Available at: http://www.epa.gov/endo/pubs/edsp21_work_plan_summary%20_overview_final.pdf. Accessed November 15, 2012.
9. EPA. (2012). ACToR: Aggregated Computational Toxicology Resource. Available at: http://actor.epa.gov/actor/faces/ACToRHome.jsp. Accessed November 15, 2012.
10. FQPA. (1996). http://www.epa.gov/opp00001/regulating/laws/fqpa/. Accessed November 13, 2012.
11. Gaulton, A., Bellis, L. J., Bento, A. P., Chambers, J., Davies, M., Hersey, A., Light, Y., McGlinchey, S., Michalovich, D., Al-Lazikani, B., et al. (2012). ChEMBL: A large-scale bioactivity database for drug discovery. Nucleic Acids Res. 40, D1100-D1107.
12. Hall, J. M., and McDonnell, D. P. (2005). Coregulators in nuclear estrogen receptor action: From concept to therapeutic targeting. Mol. Interv. 5, 343-357.
13. Hong, H., Branham, W. S., Dial, S. L., Moland, C. L., Fang, H., Shen, J., Perkins, R., Sheehan, D., and Tong, W. (2012). Rat a-Fetoprotein binding affinities of a large set of structurally diverse chemicals elucidated the relationships between structures and binding affinities. Chem. Res. Toxicol. 25, 2553-2566.
14. Hong, H., Xie, Q., Ge, W., Qian, F., Fang, H., Shi, L., Su, Z., Perkins, R., and Tong, W. (2008). Mold(2), molecular descriptors from 2D structures for chemoinformatics and toxicoinformatics. J. Chem. Inf. Model. 48, 1337-1344.
15. Kavlock, R. J., Austin, C. P., and Tice, R. R. (2009). Toxicity testing in the 21st century: Implications for human health risk assessment. Risk Anal. 29, 485-487.
16. Knox, C., Law, V., Jewison, T., Liu, P., Ly, S., Frolkis, A., Pon, A., Banco, K., Mak, C., Neveu, V., et al. (2011). DrugBank 3.0: A comprehensive resource for 'omics' research on drugs. Nucleic Acids Res. 39, D1035-D1041.
17. Komm, B. S., and Chines, A. A. (2012). An update on selective estrogen receptor modulators for the prevention and treatment of osteoporosis. Maturitas 71, 221-226.
18. Luu-The, V., and Labrie, F. (2010). The intracrine sex steroid biosynthesis pathways. Prog. Brain Res. 181, 177-192.
19. Miller, W. L. (2002). Androgen biosynthesis from cholesterol to DHEA. Mol. Cell. Endocrinol. 198, 7-14.
20. Minutolo, F., Macchia, M., Katzenellenbogen, B. S., and Katzenellenbogen, J. A. (2011). Estrogen receptor ß ligands: Recent advances and biomedical applications. Med. Res. Rev. 31, 364-442.
21. Nelson, L. R., and Bulun, S. E. (2001). Estrogen production and action. J. Am. Acad. Dermatol. 45, S116-S124.
22. Safe, S., and Kim, K. (2008). Non-classical genomic estrogen receptor (ER)/ specificity protein and ER/activating protein-1 signaling pathways. J. Mol. Endocrinol. 41, 263-275.
23. SDWA Amendments. (1996). http://water.epa.gov/lawsregs/guidance/sdwa/theme.cfm. Accessed November 13, 2012.
24. Shanle, E. K., and Xu, W. (2011). Endocrine disrupting chemicals targeting estrogen receptor signaling: Identification and mechanisms of action. Chem. Res. Toxicol. 24, 6-19.
25. Shannon, C. E. (1948). A mathematical theory of communication. Bell Syst. Tech. J. 27, 379-423.
26. Shen, J., Jiang, J., Kuang, G., Tan, C., Liu, G., Huang, J., and Tang, Y. (2012). Discovery and structure-activity analysis of selective estrogen receptor modulators via similarity-based virtual screening. Eur. J. Med. Chem. 54, 188-196.
27. Shen, J., Tan, C., Zhang, Y., Li, X., Li, W., Huang, J., Shen, X., and Tang, Y. (2010). Discovery of potent ligands for estrogen receptor beta by structurebased virtual screening. J. Med. Chem. 53, 5361-5365.
28. Silverman, S. L. (2010). New selective estrogen receptor modulators (SERMs) in development. Curr. Osteoporos. Rep. 8, 151-153.
29. Tice, R. R., Austin, C. P., Kavlock, R. J., and Bucher, J. R. (2013). Improving the human hazard characterization of chemicals: A tox21 update. Environ. Health Perspect. 121, 756-765.
30. Tong, W., Hong, H., Fang, H., Xie, Q., and Perkins, R. (2003). Decision forest: Combining the predictions of multiple independent decision tree models. J. Chem. Inf. Comput. Sci. 43, 525-531.
31. Tong, W., Xie, Q., Hong, H., Shi, L., Fang, H., and Perkins, R. (2004). Assessment of prediction confidence and domain extrapolation of two structure- activity relationship models for predicting estrogen receptor binding activity. Environ. Health Perspect. 112, 1249-1254.
32. Wang, Y., Xiao, J., Suzek, T. O., Zhang, J., Wang, J., and Bryant, S. H. (2009). PubChem: A public information system for analyzing bioactivities of small molecules. Nucleic Acids Res. 37, W623-W633.
33. Watson, C. S., Jeng, Y. J., and Kochukov, M. Y. (2010). Nongenomic signaling pathways of estrogen toxicity. Toxicol. Sci. 115, 1-11.
34. Wexler, P. (2001). TOXNET: An evolving web resource for toxicology and environmental health information. Toxicology 157, 3-10.
35. Wiese, T. E., Polin, L. A., Palomino, E., and Brooks, S. C. (1997). Induction of the estrogen specific mitogenic response of MCF-7 cells by selected analogues of estradiol-17 beta: A 3D QSAR study. J. Med. Chem. 40, 3659-3669.
36. Willett, C. E., Bishop, P. L., and Sullivan, K. M. (2011). Application of an integrated testing strategy to the U.S. EPA endocrine disruptor screening program. Toxicol. Sci. 123, 15-25.
37. Wilson, M. R. (2009). The Endocrine System: Hormones, Growth, and Development. The Rosen Publishing Group, New York, NY. Wormke, M., Stoner, M., Saville, B., Walker, K., Abdelrahim, M., Burghardt, R., and Safe, S. (2003). The aryl hydrocarbon receptor mediates degradation of estrogen receptor alpha through activation of proteasomes. Mol. Cell. Biol. 23, 1843-1855.
38. Yager, J. D., and Davidson, N. E. (2006). Estrogen carcinogenesis in breast cancer. N. Engl. J. Med. 354, 270-282.
39. Zoeller, R. T., Brown, T. R., Doan, L. L., Gore, A. C., Skakkebaek, N. E., Soto, A. M., Woodruff, T. J., and Vom Saal, F. S. (2012). Endocrine-disrupting chemicals and public health protection: A statement of principles from The Endocrine Society. Endocrinology 153, 4097-4110.